416 related articles for article (PubMed ID: 28254463)
1. Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease.
Gionchetti P; Rizzello F; Annese V; Armuzzi A; Biancone L; Castiglione F; Comberlato M; Cottone M; Danese S; Daperno M; D'Incà R; Fries W; Kohn A; Orlando A; Papi C; Vecchi M; Ardizzone S;
Dig Liver Dis; 2017 Jun; 49(6):604-617. PubMed ID: 28254463
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
3. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
Biancone L; Annese V; Ardizzone S; Armuzzi A; Calabrese E; Caprioli F; Castiglione F; Comberlato M; Cottone M; Danese S; Daperno M; D'Incà R; Frieri G; Fries W; Gionchetti P; Kohn A; Latella G; Milla M; Orlando A; Papi C; Petruzziello C; Riegler G; Rizzello F; Saibeni S; Scribano ML; Vecchi M; Vernia P; Meucci G;
Dig Liver Dis; 2017 Apr; 49(4):338-358. PubMed ID: 28161290
[TBL] [Abstract][Full Text] [Related]
4. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.
Orlando A; Armuzzi A; Papi C; Annese V; Ardizzone S; Biancone L; Bortoli A; Castiglione F; D'Incà R; Gionchetti P; Kohn A; Poggioli G; Rizzello F; Vecchi M; Cottone M; ;
Dig Liver Dis; 2011 Jan; 43(1):1-20. PubMed ID: 20843756
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Markowitz J; Grancher K; Mandel F; Daum F
Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
[TBL] [Abstract][Full Text] [Related]
6. The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.
Fascì-Spurio F; Meucci G; Papi C; Saibeni S;
Dig Liver Dis; 2017 Oct; 49(10):1092-1097. PubMed ID: 28801181
[TBL] [Abstract][Full Text] [Related]
7. Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.
Panaccione R; Rutgeerts P; Sandborn WJ; Feagan B; Schreiber S; Ghosh S
Aliment Pharmacol Ther; 2008 Sep; 28(6):674-88. PubMed ID: 18532990
[TBL] [Abstract][Full Text] [Related]
8. [Inflammatory bowel disease--diagnosis and therapy].
Vogt W
Praxis (Bern 1994); 2005 Feb; 94(5):145-50. PubMed ID: 15745379
[TBL] [Abstract][Full Text] [Related]
9. [Inflammatory bowel diseases: conservative therapy].
Bansky G
Ther Umsch; 1991 Jul; 48(7):464-70. PubMed ID: 1926006
[TBL] [Abstract][Full Text] [Related]
10. General principles of medical therapy of inflammatory bowel disease.
Friedman S
Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
[TBL] [Abstract][Full Text] [Related]
11. Optimizing therapy for inflammatory bowel disease.
Robinson M
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease revisited: newer drugs.
Hanauer SB
Scand J Gastroenterol Suppl; 1990; 175():97-106. PubMed ID: 1978406
[TBL] [Abstract][Full Text] [Related]
13. The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children.
Mutalib M; Borrelli O; Blackstock S; Kiparissi F; Elawad M; Shah N; Lindley K
J Crohns Colitis; 2014 Dec; 8(12):1730-4. PubMed ID: 25240477
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.
Humbert S; Guilpain P; Puéchal X; Terrier B; Rivière S; Mahr A; Pagnoux C; Bagnères D; Cordier JF; Le Quellec A; Altwegg R; Guillevin L;
Rheumatology (Oxford); 2015 Nov; 54(11):1970-5. PubMed ID: 26106214
[TBL] [Abstract][Full Text] [Related]
15. [Treatment strategies for inflammatory bowel disease].
Lémann M; Allez M
Rev Prat; 2005 May; 55(9):984-92. PubMed ID: 16052969
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care.
Poppers DM; Scherl EJ
Inflamm Bowel Dis; 2008 Jan; 14(1):106-13. PubMed ID: 17886285
[TBL] [Abstract][Full Text] [Related]
17. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
Bröms G; Granath F; Stephansson O; Kieler H
Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
[TBL] [Abstract][Full Text] [Related]
18. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pharmacotherapy recommendations in guidelines for inflammatory bowel disease.
Wang X; Yang YM; Yang T; An LY; Chen XZ; Qi YX; He HY; Fan HB; Sun DL
J Clin Pharm Ther; 2021 Jun; 46(3):599-609. PubMed ID: 33543814
[TBL] [Abstract][Full Text] [Related]
20. Conventional drug therapy for inflammatory bowel disease.
Bryant RV; Brain O; Travis SP
Scand J Gastroenterol; 2015 Jan; 50(1):90-112. PubMed ID: 25523560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
